In vivo models of metastatic PCa have shown that co-expression of TGFβRdn on PSMA-targeted CAR-T cells result in increased T-cell proliferation, increased cytokine secretion, resistance to exhaustion, long-term persistence, and enhanced tumor eradication [99]. The gene discussed is FOLH1; the disease is neoplasm.